Meetings

Tuesday, September 1, 2020

The level of discordance between pathologists, and the differences in operationalizing liver biopsy collection in trial protocols have been frequently raised as major issues and areas of concern for NASH clinical trials.

The goal of this session was to discuss issues including: inter/intra-observer variability, scoring systems, and technical and logistical considerations.

Tuesday, August 11, 2020

Since the previous in-person Liver Forum meeting in September 2019, there have been several clinical trial result read-outs, new publications, biomarker consortia news, and regulatory activity. This 2-hour webinar provided a platform for short overview presentations of updates from some of the groups that comprise the Liver Forum.